Bilateral Percutaneous Nephrolithomy
Primary Purpose
Nephrolithiasis of Both Kidneys
Status
Recruiting
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
PCNL
Sponsored by
About this trial
This is an interventional treatment trial for Nephrolithiasis of Both Kidneys
Eligibility Criteria
Inclusion Criteria:
All subjects with a clinical diagnosis of struvite calculi will potentially be included. Specific inclusion criteria include the following:
- Age >18 years
- Any patient with bilateral stone burden eligible and appropriate for PCNL procedure
- Medically fit for definitive surgical management of stone.
Exclusion Criteria:
Patients with any of the following characteristics will not be eligible for the present study:
- Those with medical comorbidities preventing them from safely undergoing definitive surgical therapy.
- Patients who are unable to provide informed consent.
- Patients who are planned for alternative procedures (ureteroscopy, extracorporeal shock wave lithotripsy)
- Anyone who is unable to give their informed consent
- Anyone under the age of 19
- Anyone who, in the opinion of the PI, is unfit or unsuitable to participate in the study
Sites / Locations
- University of British ColumbiaRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Simultaneous Bilateral PCNL
Unilateral PCNL
Arm Description
Patients undergo simultaneous bilateral PCNL.
Patients undergoing unilateral staged PCNL.
Outcomes
Primary Outcome Measures
Stone Free Rates Measured using Chi-Square analysis.
Rate of clearance of kidney stones following the procedure.
Number of Participants with Repeat procedures
Number of Participants requiring repeat surgical procedures for residual stones following initial treatment.
Secondary Outcome Measures
Length of hospital stay
Hospital stay for simultaneous bilateral versus staged PCNL.
Number of Participants with Complications
Number of participants with perioperative complication and rates for each procedure.
Patient Quality of Life
Quality of life assessment comparing the two different procedures will be conducted with the Wisconsin Stone Quality of Life questionnaire (WISQOL). WISQOL is a disease-specific, health-related quality of life measure designed for patients who form kidney stones. This questionnaire has 4 different domains: social-domain 1, emotional-domain 2, stone related-domain 3 and vitality-domain 4. In the questionnaire, patients are to answer between 1 (Very true) to 5 (Not true at all). 1 is the worst outcome, and 5 is the best outcome.
Full Information
NCT ID
NCT03924362
First Posted
March 26, 2019
Last Updated
May 16, 2022
Sponsor
University of British Columbia
1. Study Identification
Unique Protocol Identification Number
NCT03924362
Brief Title
Bilateral Percutaneous Nephrolithomy
Official Title
A Prospective Trial of Feasibility and Efficacy of Simultaneous Bilateral Percutaneous Nephrolithotomy
Study Type
Interventional
2. Study Status
Record Verification Date
May 2022
Overall Recruitment Status
Recruiting
Study Start Date
September 30, 2019 (Actual)
Primary Completion Date
December 31, 2023 (Anticipated)
Study Completion Date
December 31, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of British Columbia
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to determine the effective regimen for definitive surgical therapy of bilateral kidney stones. It is unknown whether patients who undergo simultaneous bilateral percutaneous nephrolithotomy (PCNL) experience improved post-operative outcomes compared to patients who have staged unilateral procedures.
Detailed Description
Purpose:
The aim of this research is to determine an effective regimen for definitive surgical therapy of bilateral kidney stones. It is unknown whether patients who undergo simultaneous bilateral percutaneous nephrolithotomy (PCNL) experience improved post-operative outcomes compared to patients who have staged unilateral procedures.
Hypothesis and Justification The gold standard for surgical management of large kidney stones is percutaneous nephrolithotomy (PCNL). A large renal stone burden has been defined as >20mm. In addition, PCNL has improved stone-free rates for lower pole calculi >10mm compared to alternative treatments. Guidelines encourage removal of staghorn calculi for surgical candidates (Assimos et al., 2016). Patients with bilateral large stone burdens have been managed with one of two general options: (i) a single procedure in which both kidneys are operated upon or (ii) two separate procedures in which only one kidney is addressed per procedure. However, there are no prospectively performed peer-reviewed studies directly comparing the two practices. The investigators seek to determine whether there is a significant difference in patient outcomes based on the surgical regimen chosen.
The investigators hypothesize that in comparison to unilateral PCNL (U-PCNL), simultaneous bilateral PCNL (SB-PCNL) under one anesthetic results in comparable
stone free rates
re-intervention rates for residual stones and
perioperative complication rates
Objectives
The objectives are:
To provide clinical data on outcomes following simultaneous bilateral and staged percutaneous nephrolithotomy for renal and ureteral calculi
To determine patient preference with respect to simultaneous versus staged PCNL
Research Design This study will be a prospective, non-randomized, multi-centre, non-blinded trial. Participants will be accrued through the Vancouver General Hospital Stone Center who have been referred for bilateral stones or have been seen in consultation for bilateral stones at the Department of Urologic Sciences and are scheduled for a percutaneous nephrolithotomy (PCNL). Consent forms and Letters of Introduction outlining the study will be given to patients by a research coordinator once the decision is made to book surgery. Patients will have at least 24 hours to decide to participate. Patients will receive surgical management for their stones in the form of PCNL. A computed tomography (CT) scan of the kidneys will be performed post-operatively by week 6 to determine if any residual stone fragments are present. Patients will be seen in follow up at 3 months in clinic after undergoing a follow up CT KUB, renal ultrasound, or KUB as necessary to evaluate stone clearance.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Nephrolithiasis of Both Kidneys
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Patients will be managed either with simultaneous bilateral procedures or staged unilateral procedures based on surgeon's routine practice pattern. Additional surgical interventional will be dependent on initial patient stone-free outcomes.
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
92 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Simultaneous Bilateral PCNL
Arm Type
Active Comparator
Arm Description
Patients undergo simultaneous bilateral PCNL.
Arm Title
Unilateral PCNL
Arm Type
Active Comparator
Arm Description
Patients undergoing unilateral staged PCNL.
Intervention Type
Procedure
Intervention Name(s)
PCNL
Intervention Description
Percutaneous Nephrolithotomy is a means of treating large kidney stone burdens.
Primary Outcome Measure Information:
Title
Stone Free Rates Measured using Chi-Square analysis.
Description
Rate of clearance of kidney stones following the procedure.
Time Frame
3 months.
Title
Number of Participants with Repeat procedures
Description
Number of Participants requiring repeat surgical procedures for residual stones following initial treatment.
Time Frame
3 months.
Secondary Outcome Measure Information:
Title
Length of hospital stay
Description
Hospital stay for simultaneous bilateral versus staged PCNL.
Time Frame
3 months.
Title
Number of Participants with Complications
Description
Number of participants with perioperative complication and rates for each procedure.
Time Frame
3 months.
Title
Patient Quality of Life
Description
Quality of life assessment comparing the two different procedures will be conducted with the Wisconsin Stone Quality of Life questionnaire (WISQOL). WISQOL is a disease-specific, health-related quality of life measure designed for patients who form kidney stones. This questionnaire has 4 different domains: social-domain 1, emotional-domain 2, stone related-domain 3 and vitality-domain 4. In the questionnaire, patients are to answer between 1 (Very true) to 5 (Not true at all). 1 is the worst outcome, and 5 is the best outcome.
Time Frame
3 months.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
All subjects with a clinical diagnosis of struvite calculi will potentially be included. Specific inclusion criteria include the following:
Age >18 years
Any patient with bilateral stone burden eligible and appropriate for PCNL procedure
Medically fit for definitive surgical management of stone.
Exclusion Criteria:
Patients with any of the following characteristics will not be eligible for the present study:
Those with medical comorbidities preventing them from safely undergoing definitive surgical therapy.
Patients who are unable to provide informed consent.
Patients who are planned for alternative procedures (ureteroscopy, extracorporeal shock wave lithotripsy)
Anyone who is unable to give their informed consent
Anyone under the age of 19
Anyone who, in the opinion of the PI, is unfit or unsuitable to participate in the study
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Victor Wong
Phone
604-875-4111
Ext
62421
Email
kfvwong@alumni.ubc.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ben Chew, MD
Organizational Affiliation
University of British Columbia, Associate Professor
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of British Columbia
City
Vancouver
State/Province
British Columbia
ZIP/Postal Code
V5Z1M9
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Victor Wong, BSc
Phone
6048754111
Ext
62421
Email
victor.kf.wong@ubc.ca
First Name & Middle Initial & Last Name & Degree
Ben H Chew, MD
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
The University of British Columbia is the main site of the study, therefore all data will be transferred from the subsites to the University of British Columbia, and no transfer of data to the subsites. Any data transfer will be de-identified.
Citations:
PubMed Identifier
27238615
Citation
Assimos D, Krambeck A, Miller NL, Monga M, Murad MH, Nelson CP, Pace KT, Pais VM Jr, Pearle MS, Preminger GM, Razvi H, Shah O, Matlaga BR. Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART II. J Urol. 2016 Oct;196(4):1161-9. doi: 10.1016/j.juro.2016.05.091. Epub 2016 May 27.
Results Reference
background
PubMed Identifier
28326800
Citation
Jones P, Dhliwayo B, Rai BP, Mokete M, Amitharaj R, Aboumarzouk OM, Somani BK. Safety, Feasibility, and Efficacy of Bilateral Synchronous Percutaneous Nephrolithotomy for Bilateral Stone Disease: Evidence from a Systematic Review. J Endourol. 2017 Apr;31(4):334-340. doi: 10.1089/end.2016.0851. Epub 2017 Mar 22.
Results Reference
background
PubMed Identifier
29245347
Citation
Kang SK, Cho KS, Kang DH, Jung HD, Kwon JK, Lee JY. Systematic review and meta-analysis to compare success rates of retrograde intrarenal surgery versus percutaneous nephrolithotomy for renal stones >2 cm: An update. Medicine (Baltimore). 2017 Dec;96(49):e9119. doi: 10.1097/MD.0000000000009119.
Results Reference
background
PubMed Identifier
27889419
Citation
Penniston KL, Antonelli JA, Viprakasit DP, Averch TD, Sivalingam S, Sur RL, Pais VM Jr, Chew BH, Bird VG, Nakada SY. Validation and Reliability of the Wisconsin Stone Quality of Life Questionnaire. J Urol. 2017 May;197(5):1280-1288. doi: 10.1016/j.juro.2016.11.097. Epub 2016 Nov 23.
Results Reference
background
PubMed Identifier
15072621
Citation
Silverstein AD, Terranova SA, Auge BK, Weizer AZ, Delvecchio FC, Pietrow PK, Munver R, Albala DM, Preminger GM. Bilateral renal calculi: assessment of staged v synchronous percutaneous nephrolithotomy. J Endourol. 2004 Mar;18(2):145-51. doi: 10.1089/089277904322959770.
Results Reference
background
PubMed Identifier
21161650
Citation
Wang CJ, Chang CH, Huang SW. Simultaneous bilateral tubeless percutaneous nephrolithotomy of staghorn stones: a prospective randomized controlled study. Urol Res. 2011 Aug;39(4):289-94. doi: 10.1007/s00240-010-0342-x. Epub 2010 Dec 16.
Results Reference
background
Learn more about this trial
Bilateral Percutaneous Nephrolithomy
We'll reach out to this number within 24 hrs